1. Home
  2. GNLX vs MTH Comparison

GNLX vs MTH Comparison

Compare GNLX & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • MTH
  • Stock Information
  • Founded
  • GNLX 2001
  • MTH 1985
  • Country
  • GNLX United States
  • MTH United States
  • Employees
  • GNLX N/A
  • MTH N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • MTH Homebuilding
  • Sector
  • GNLX Health Care
  • MTH Consumer Discretionary
  • Exchange
  • GNLX Nasdaq
  • MTH Nasdaq
  • Market Cap
  • GNLX 112.5M
  • MTH 4.9B
  • IPO Year
  • GNLX 2023
  • MTH 1988
  • Fundamental
  • Price
  • GNLX $3.44
  • MTH $73.99
  • Analyst Decision
  • GNLX Strong Buy
  • MTH Buy
  • Analyst Count
  • GNLX 4
  • MTH 10
  • Target Price
  • GNLX $17.75
  • MTH $74.42
  • AVG Volume (30 Days)
  • GNLX 152.2K
  • MTH 962.9K
  • Earning Date
  • GNLX 08-13-2025
  • MTH 07-23-2025
  • Dividend Yield
  • GNLX N/A
  • MTH 2.33%
  • EPS Growth
  • GNLX N/A
  • MTH N/A
  • EPS
  • GNLX N/A
  • MTH 9.89
  • Revenue
  • GNLX N/A
  • MTH $6,284,888,000.00
  • Revenue This Year
  • GNLX N/A
  • MTH $3.99
  • Revenue Next Year
  • GNLX N/A
  • MTH $7.59
  • P/E Ratio
  • GNLX N/A
  • MTH $7.46
  • Revenue Growth
  • GNLX N/A
  • MTH N/A
  • 52 Week Low
  • GNLX $1.60
  • MTH $59.27
  • 52 Week High
  • GNLX $5.89
  • MTH $106.99
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 65.71
  • MTH 64.26
  • Support Level
  • GNLX $2.80
  • MTH $67.88
  • Resistance Level
  • GNLX $3.61
  • MTH $76.59
  • Average True Range (ATR)
  • GNLX 0.22
  • MTH 2.64
  • MACD
  • GNLX 0.05
  • MTH 0.86
  • Stochastic Oscillator
  • GNLX 80.23
  • MTH 83.45

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

Share on Social Networks: